Aankondiging • Feb 20
Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2025 , Payable on March 31, 2026 Wesfarmers Limited announced dividend of AUD 0.95000000 per share for the six months ended December 31, 2025. Record date is February 25, 2026. Ex-date is February 25, 2025. Payment date is March 31, 2026. Aankondiging • Jan 09
Wesfarmers Limited to Report Fiscal Year 2026 Results on Aug 27, 2026 Wesfarmers Limited announced that they will report fiscal year 2026 results on Aug 27, 2026 Aankondiging • Dec 07
Wesfarmers Limited to Report First Half, 2026 Results on Feb 19, 2026 Wesfarmers Limited announced that they will report first half, 2026 results on Feb 19, 2026 Aankondiging • Oct 31
Wesfarmers Limited Announces Cessation of Jennifer Anne Westacott as Director, Effective 30 October 2025 Wesfarmers Limited announced cessation of Jennifer Anne Westacott as director. Date that director ceased to be director: 30 October 2025. Aankondiging • Sep 05
Wesfarmers Limited, Annual General Meeting, Oct 30, 2025 Wesfarmers Limited, Annual General Meeting, Oct 30, 2025. Location: at the perth convention and exhibition centre, mounts bay road, perth, western australia Australia Aankondiging • Aug 30
Wesfarmers Limited Announces Board Changes Wesfarmers Limited announced that its Board has resolved to appoint Mr. Ken MacKenzie as Chairman to succeed Michael Chaney from the conclusion of Wesfarmers' 2026 Annual General Meeting (AGM), expected to be held on 29 October 2026. Mr. MacKenzie will join the Board of Wesfarmers on 1 June 2026. Mr. Chaney announced he would retire at the end of his current three-year term. Mr. Chaney's retirement will mark the end of a long and successful career at Wesfarmers, including separate periods in which he has served as Chairman and as Managing Director. He joined Wesfarmers in 1983 as Company Secretary and Administration Manager and became Finance Director in 1984. Mr. Chaney was appointed Managing Director in July 1992 and retired from that position in July 2005. He re-joined the Board as a non-executive director in June 2015, becoming Chairman in November 2015. Mr. MacKenzie has extensive experience as a chairman and senior executive in large, complex businesses operating across multiple industries and jurisdictions. Most recently Mr. MacKenzie was the Chair of BHP Group Limited, from September 2017 to March 2025. Before that, from 2005 to 2015, he served as Managing Director and Chief Executive Officer of Amcor Limited, a global packaging company. Mr. MacKenzie is currently the Chair of Melbourne Business School Limited (since June 2023), a member of the Advisory Board of American Securities Capital Partners LLC (since January 2016) and is a part-time adviser at Barrenjoey (since April 2021). Aankondiging • Aug 28
Wesfarmers Limited, Annual General Meeting, Oct 29, 2026 Wesfarmers Limited, Annual General Meeting, Oct 29, 2026. Aankondiging • Jul 02
Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES). Supagas Holding Pty Ltd agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd.
The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025.Damien Roberts of Herbert Smith Freehills acted as a legal advisor to Coregas. As of June 26 ,2025, Wesfarmers announced that all conditions precedent to the sale of Coregas to a subsidiary of Nippon Sanso Holdings Corporation have now been satisfied and sale is now unconditional. The transaction is expected to be completed in July 2025. The sale subject to the receipt of certain consents and approvals, including from the Australian Competition and Consumer Commission and Foreign Investment Review Board, which have now been received.
Supagas Holding Pty Ltd completed the acquisition Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) on July 1, 2025. Wesfarmers expects to record a pre-tax profit on sale of approximately AUD 230 million to AUD 260 million, subject to completion adjustments, with this amount to be included in the results for the 2025 financial year.
Daniel Coote, Kapil Kumar, Martin Linhart, Pulin Desai and Fady Abi Abdallah of BDO Corporate Finance (QLD) Limited acted as due diligence provider for Supagas Holding Pty Ltd. Aankondiging • Mar 08
Wesfarmers Announces to Wind Up BPI No 1 Pty Ltd. Property Structure in September 2025 Wesfarmers announced that it will wind up the BPI No 1 Pty Ltd. property structure in September 2025. This will involve Wesfarmers taking full ownership of the fifteen Bunnings warehouse properties ("the properties") that are currently in the BPI structure. In August 2013, Wesfarmers established BPI as a wholly owned, special purpose vehicle to facilitate the sale and leaseback of the properties via a securitised lease transaction. The sale and leaseback was funded primarily from the issuance by BPI of twelve-year senior secured notes to investors. Subject to the independent valuation, Wesfarmers is expected to record a one-off pre-tax profit associated with the transaction of between $80 million and $130 million in the 2025 financial year. The one-off impact to Wesfarmers' earnings reflects the expected fair value uplift associated with the properties and the unwind of the property structure. Wesfarmers will undertake a strategic review of the properties, which will include exploring a range of capital management options once the BPI structure is unwound. Aankondiging • Dec 21
Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million. Nippon Sanso Holdings Corporation (TSE:4091) agreed to acquire Coregas Pty Ltd from Wesfarmers Limited (ASX:WES) for AUD 770 million on December 20, 2024. A cash consideration of AUD 770 million will be paid by Nippon Sanso Holdings Corporation. As part of consideration, AUD 770 million is paid towards common equity of Coregas Pty Ltd.
The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The expected completion of the transaction is May 1, 2025 to August 31, 2025. Buy Or Sell Opportunity • Oct 17
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 1.4% to €43.76. The fair value is estimated to be €36.22, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 3.9%. For the next 3 years, revenue is forecast to grow by 4.1% per annum. Earnings are also forecast to grow by 8.3% per annum over the same time period. Buy Or Sell Opportunity • Sep 12
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 2.7% to €42.61. The fair value is estimated to be €35.28, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 3.9%. For the next 3 years, revenue is forecast to grow by 4.1% per annum. Earnings are also forecast to grow by 8.2% per annum over the same time period. Aankondiging • Sep 03
Wesfarmers Limited Announces Resignation of Robert Geoffrey Scott as Director Wesfarmers Limited announced the resignation of Robert Geoffrey Scott as director. Date of last notice is on 24 May 2024. Declared Dividend • Sep 01
Final dividend of AU$1.07 announced Shareholders will receive a dividend of AU$1.07. Ex-date: 3rd September 2024 Payment date: 9th October 2024 Dividend yield will be 3.6%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (64% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 30
Full year 2024 earnings released: EPS: AU$2.26 (vs AU$2.18 in FY 2023) Full year 2024 results: EPS: AU$2.26 (up from AU$2.18 in FY 2023). Revenue: AU$44.2b (up 1.5% from FY 2023). Net income: AU$2.56b (up 3.7% from FY 2023). Profit margin: 5.8% (up from 5.7% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Multiline Retail industry in Europe. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 8% per year. Aankondiging • Aug 15
Macquarie and Wesfarmers Reportedly Join the Race for $3 Billion I-MED Sale Wesfarmers Limited (ASX:WES) and Macquarie Group Limited (ASX:MQG) are the latest names to emerge as a keen competitors for the $3 billion diagnostic imaging business I-MED Holdings Pty Limited, which is about to hit the market. It comes after Wesfarmers is understood to have carried out detailed analysis of I-MED, as it focuses on the healthcare industry for acquisitions. No doubt acquisitions in healthcare will be discussed when Wesfarmers, which owns retail brands including Target, Kmart and Officeworks, reports its full year results on August 29. Meanwhile, Macquarie would look at I-MED through its infrastructure arm Macquarie Asset Management, and is believed to be keen to get a partner to assess the opportunity. DataRoom revealed that Morgan Stanley was about to be hired to sell I-MED, with Bain Capital and Morgan Stanley Infrastructure Partners interested suitors. Jefferies Australia is also now advising. A number of other global private equity firms are also lining up to take a look, say sources. Buy Or Sell Opportunity • Aug 14
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 3.4% to €44.25. The fair value is estimated to be €36.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 6.7%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 8.3% per annum over the same time period. Aankondiging • Aug 12
Private Equity Reportedly Pursues Ramsay A European private equity firm is understood to be running the ruler over the $10 billion Ramsay Health Care Limited (ASX:RHC), with an eye to becoming the second group in two years to launch a buyout proposal for the nation's largest private hospital operator. Ramsay last week flagged that it would deliver weaker-than-expected earnings for the full year as it wrote down the value of its European operation. The hospital operator, which is scheduled to release its full-year results on August 30, told the ASX last Monday that its underlying net profit was expected to be in the range of $265 million to $270 million, compared with $278.2 million the previous year. Ramsay was considered a takeover target earlier this year, with the Perth-based conglomerate Wesfarmers known to be running the ruler over the business some time ago. It is understood that Wesfarmers Limited (ASX:WES), which recently appointed Ramsay's former chief operating officer Kate Munnings, to its board carried out extensive and detailed work on a potential buyout of Ramsay and an acquisition of the country's largest diagnostic imaging provider I-MED, which is expected to be put on the block next month for about $3 billion through Morgan Stanley and Jefferies. However, Wesfarmers thought Ramsay would have to be far cheaper before it would make its move - despite Ramsay's share price being at its lowest level in a decade, about a third cheaper than it was after Kohlberg Kravis Roberts bid for the business in 2022. Some think the European suitor may be CVC, while Partners Group, which is also based in Europe, has looked at Australian healthcare company Healius, and EQT could also be an acquirer. Other European funds that invest in healthcare include Permira, PAI and Intermediate Capital. Some think a company with real estate expertise would be the most likely to have interest because of Ramsay's lucrative portfolio of hospital assets in Australia. There's also a view that any deal involving Ramsay would unfold after it has demerged or sold its Ramsay Sante operation in Europe. Ramsay, whose David Thodey-led board recently appointed former Woolworths executive Natalie Davis as chief executive to replace Craig McNally, has been trying to find a solution for that part of the company, which has lagged in performance. Ramsay Health Care owns 52.79% of Ramsay Sante, the second-largest private care provider in Europe, and a sale would help to reduce its $4.7 billion of debt. Buyers are not interested in the whole business, but it could try to sell a stake. Buy Or Sell Opportunity • Jul 05
Now 21% overvalued The stock has been flat over the last 90 days, currently trading at €40.55. The fair value is estimated to be €33.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 6.7%. For the next 3 years, revenue is forecast to grow by 3.9% per annum. Earnings are also forecast to grow by 8.5% per annum over the same time period. Aankondiging • May 02
Wesfarmers Limited Announces Executive Changes Wesfarmers Limited announced that Ian Hansen, Managing Director of Wesfarmers Chemicals, Energy and Fertilisers (WesCEF) has advised of his intention to retire in November 2024. Mr. Hansen will remain with WesCEF and Wesfarmers in an advisory capacity to ensure a smooth transition and provide ongoing support on key projects, including the Group's lithium business, where he will remain Chairman of Covalent Lithium. Mr. Hansen will be succeeded by Aaron Hood, WesCEF's Chief Operating Officer. Prior to his current role Mr. Hood held other senior executive positions within the Group, including Chief Financial Officer of WesCEF and Executive General Manager of Business Development at Wesfarmers. He is also a director of the Covalent Lithium joint venture. Wesfarmers Managing Director Rob Scott said Mr. Hood's skills and experience made him a logical successor to Mr. Hansen. Mr. Hood has been appointed Deputy Managing Director of WesCEF effective 2 May 2024 and will also retain responsibilities as Chief Operating Officer until he commences as the Managing Director of WesCEF in November 2024. Aankondiging • Apr 24
Wesfarmers Reportedly Runs the Ruler over Ramsay Health Care The $74 billion Australian listed conglomerate Wesfarmers Limited (ASX:WES) is understood to have been carrying out detailed work in recent months, weighing up the merits of buying Ramsay Health Care Limited (ASX:RHC). It is understood that Wesfarmers - which owns Target, Kmart, Officeworks and other industrial and healthcare assets - is interested in securing Ramsay's Australian business. However, with its shares performing strongly and a $74 billion market value, it's not inconceivable that Wesfarmers buys all of the $12 billion private hospital operator and sells off the international assets to other parties. Some believe that the timing could now be right for Wesfarmers to embark on its next major acquisition, after bedding down the 2022 purchase of Priceline pharmacy chain owner Australian Pharmaceutical Industries for $763 million to seed its healthcare unit. Whether it remains serious about a deal remains unclear. Wesfarmers is usually assessing the acquisition of a handful of targets at any given time, and maintains an active mergers and acquisitions team. It has looked at plenty of opportunities in the past before opting to walk away, and can treat targets as simply a due diligence exercise. Another possibility is that it could simply be weighing up a tilt at Ramsay's pharmacy unit, which it has expressed interest in before. Still, Wesfarmers' share price has rallied since the start of this year so it could take advantage of that, while the healthcare sector has been struggling with high costs and staff shortages, dampening the performance of Australian listed stocks trading in the space, including Ramsay. Also weighing in Wesfarmers' favour is the fact that Ramsay's shareholders have been unhappy with the company's performance since Kohlberg Kravis Roberts walked away from a bid in 2022, causing its share price to tumble, and the could be more open to a buyout. The David Thodey-chaired Ramsay is believed to be thinking about a potential exit from its European hospital owner, Ramsay Sante, in which it has a 52.79% stake. DataRoom understands that Wesfarmers has carried out work on all aspects of the Ramsay business, including its real estate, and has been speaking to healthcare funds and industry figures. Declared Dividend • Feb 18
First half dividend of AU$0.91 announced Shareholders will receive a dividend of AU$0.91. Ex-date: 20th February 2024 Payment date: 27th March 2024 Dividend yield will be 4.0%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 29% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Aankondiging • Feb 17
Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2023, Payable on March 27, 2024 Wesfarmers Limited announced dividend for the six months ended December 31, 2023 of AUD 0.91000000 per share. Record date is February 21, 2024. Ex-date is February 20, 2024. Payment date is March 27, 2024. Reported Earnings • Feb 16
First half 2024 earnings released: EPS: AU$1.26 (vs AU$1.22 in 1H 2023) First half 2024 results: EPS: AU$1.26 (up from AU$1.22 in 1H 2023). Revenue: AU$22.7b (flat on 1H 2023). Net income: AU$1.43b (up 3.0% from 1H 2023). Profit margin: 6.3% (up from 6.1% in 1H 2023). Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Multiline Retail industry in Europe. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 3% per year. Buying Opportunity • Oct 26
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be €37.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 12%. For the next 3 years, revenue is forecast to grow by 3.2% per annum. Earnings is also forecast to grow by 6.9% per annum over the same time period. Aankondiging • Sep 07
TPG Capital Reportedly Tests Buyer Interest for the $3.5 Billion-Plus Greencross Speculation is mounting that TPG Capital, L.P. is testing buyer interest for the $3.5 billion-plus Petbarn owner Greencross Limited and some are pointing to Wesfarmers Limited (ASX:WES) as the potential suitor. Working on a potential sale of the business, which owns veterinary clinics and a trans-Tasman pet care retail business, is investment bank Jefferies LLC, and there is a view that the $60 billion listed Perth-based Wesfarmers is showing some interest. The question is whether TPG would sell the company as a whole or just the interest that it retained after offloading 45% to AustralianSuper and The Healthcare of Ontario Pension Plan. That deal last year valued the business at $3.5 billion, and since then, Greencross has purchased Habitat Pet Supplies, a Melbourne-based pet store chain with five stores that it plans to merge with its Petbarn and Animates retail business. The logic is all there for Wesfarmers to buy Greencross. The question is whether it would buy off TPG - expected to have overly enthusiastic expectations on price. Yet TPG has already pocketed $1.57 billion through its sell down so perhaps the price tag won't be that large after all. Wesfarmers, which did not comment on whether it was weighing an acquisition, would be familiar with the business given it looked at Greencross when Credit Suisse and Morgan Stanley ran a sale process in 2021. Reported Earnings • Aug 25
Full year 2023 earnings released: EPS: AU$2.18 (vs AU$2.08 in FY 2022) Full year 2023 results: EPS: AU$2.18 (up from AU$2.08 in FY 2022). Revenue: AU$43.6b (up 18% from FY 2022). Net income: AU$2.47b (up 4.8% from FY 2022). Profit margin: 5.7% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Multiline Retail industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Aankondiging • Aug 25
Wesfarmers Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on October 5, 2023 Wesfarmers Limited announced dividend of AUD 1.03 per share for the six months ended June 30, 2023. Ex-date is August 30, 2023. Record date is August 31, 2023. Payment date is October 5, 2023. Aankondiging • Jun 27
Wesfarmers Limited Announces Management Changes Wesfarmers Limited announced that Vicki Robinson has advised of her intention to retire as Company Secretary, effective 30 October 2023, to focus on non-executive opportunities. Ms. Robinson will be succeeded as Company Secretary and as a member of the Wesfarmers Leadership Team by Sheldon Renkema. Mr. Renkema joined Wesfarmers in 2007 and is currently General Manager of Business Development for Wesfarmers Chemicals, Energy and Fertilisers, having previously held senior positions leading the corporate and retail legal teams within the Wesfarmers Corporate Solicitors Office. Wesfarmers Managing Director, Rob Scott, thanked Ms. Robinson for her significant contribution to Wesfarmers over the last 20 years and congratulated Mr. Renkema on his appointment. Aankondiging • May 09
Wesfarmers Reportedly Among Suitors for Alinta Assets Wesfarmers Limited (ASX:WES) is understood to be among the suitors looking to acquire Alinta Energy Pty Limited's West Australian assets. First-round bids for the assets are due on May 12 in the Goldman Sachs-run competition. Sources say the motivation of the $58 billion listed conglomerate is to gain additional sources of power, and it would be compelled by the renewable energy component of the offering. Several parties are believed to be lining up for Alinta's business, including Pacific Equity Partners, which owns Zenith Energy, and the business interests of Gina Rinehart, owner of Hancock Energy and Hancock Prospecting. DataRoom understands that working with Hancock on Alinta is Highbury Partnership, which advised on the $4 billion acquisition by Chow Tai Fook of Alinta Energy in 2017 from TPG Capital. Also in the competition are private equity firm EQT Partners AB and Macquarie Group Limited (ASX:MQG), which would partner with another suitor, likely to be BP, which is also looking. Macquarie already partners with BP on its Australian Renewable Energy Hub in the Pilbara. Queensland Investment Corporation is expected to be looking through its Pacific Energy business, while CKI is believed to be bidding through Energy Developments, although the Chinese-owned group may face opposition from the Foreign Investment Review Board. There is also a view that billionaire Andrew Forrest will be around the hoop - either through his Squadron Energy or through Fortescue Metals. Investment bank Citi is mandated by a party, and sources have been pointing to either QIC or Brookfield. Based on the level of interest, some think private equity firms, and possibly APA, will not be competitive on price, going up against parties with a cheaper cost of capital. Recent Insider Transactions • Apr 16
MD, CEO & Director recently sold €5.5m worth of stock On the 11th of April, Robert Scott sold around 174k shares on-market at roughly €31.59 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Robert's only on-market trade for the last 12 months. Reported Earnings • Feb 15
First half 2023 earnings released: EPS: AU$1.22 (vs AU$1.07 in 1H 2022) First half 2023 results: EPS: AU$1.22 (up from AU$1.07 in 1H 2022). Revenue: AU$22.6b (up 27% from 1H 2022). Net income: AU$1.38b (up 14% from 1H 2022). Profit margin: 6.1% (down from 6.8% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Multiline Retail industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 18
Wesfarmers Limited to Report Q2, 2023 Results on Feb 15, 2023 Wesfarmers Limited announced that they will report Q2, 2023 results on Feb 15, 2023 Aankondiging • Oct 19
Wesfarmers Limited to Report Fiscal Year 2023 Results on Aug 25, 2023 Wesfarmers Limited announced that they will report fiscal year 2023 results on Aug 25, 2023 Reported Earnings • Aug 26
Full year 2022 earnings released: EPS: AU$2.08 (vs AU$2.10 in FY 2021) Full year 2022 results: EPS: AU$2.08 (down from AU$2.10 in FY 2021). Revenue: AU$36.8b (up 8.5% from FY 2021). Net income: AU$2.35b (down 1.2% from FY 2021). Profit margin: 6.4% (down from 7.0% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 2.5%, compared to a 8.8% growth forecast for the Multiline Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 12% per year. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Non-Executive Director Sharon Warburton was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Mar 12
Non Executive Director recently bought €162k worth of stock On the 8th of March, Anil Sabharwal bought around 5k shares on-market at roughly €32.49 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €385k more in shares than they have sold in the last 12 months. Recent Insider Transactions • Feb 24
Non-Executive Director recently bought €51k worth of stock On the 22nd of February, Alan Cransberg bought around 2k shares on-market at roughly €32.37 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €207k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 18
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat First half 2022 results: EPS: AU$1.07 (down from AU$1.23 in 1H 2021). Revenue: AU$17.8b (flat on 1H 2021). Net income: AU$1.21b (down 13% from 1H 2021). Profit margin: 6.8% (down from 7.8% in 1H 2021). Revenue exceeded analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 3.7%, compared to a 11% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Nov 11
Upcoming dividend of AU$2.00 per share Eligible shareholders must have bought the stock before 18 November 2021. Payment date: 02 December 2021. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (1.8%). Board Change • Oct 07
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Non-Executive Director Sharon Warburton was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Recent Insider Transactions • Sep 24
Independent Non-Executive Director recently bought €70k worth of stock On the 21st of September, Michael Roche bought around 2k shares on-market at roughly €35.25 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €135k more in shares than they have sold in the last 12 months. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Director Overboarding • Sep 01
Director Sharon Warburton has joined 5th company board Sharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations. Reported Earnings • Aug 27
Full year 2021 earnings released: EPS AU$2.10 (vs AU$1.43 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$33.9b (up 10.0% from FY 2020). Net income: AU$2.38b (up 47% from FY 2020). Profit margin: 7.0% (up from 5.3% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 7% per year. Reported Earnings • Feb 20
First half 2021 earnings released: EPS AU$1.23 (vs AU$1.00 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: AU$17.8b (up 17% from 1H 2020). Net income: AU$1.39b (up 23% from 1H 2020). Profit margin: 7.8% (up from 7.4% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Feb 20
Revenue misses expectations Revenue missed analyst estimates by 0.05%. Over the next year, revenue is forecast to stay flat compared to a 8.2% growth forecast for the Multiline Retail industry in Germany. Is New 90 Day High Low • Feb 06
New 90-day high: €35.32 The company is up 21% from its price of €29.24 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Multiline Retail industry, which is also up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €33.94 per share. Is New 90 Day High Low • Jan 22
New 90-day high: €33.36 The company is up 18% from its price of €28.26 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Multiline Retail industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €35.28 per share. Is New 90 Day High Low • Jan 05
New 90-day high: €32.33 The company is up 16% from its price of €27.85 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Multiline Retail industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €34.90 per share. Is New 90 Day High Low • Dec 10
New 90-day high: €30.94 The company is up 12% from its price of €27.54 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Multiline Retail industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €29.54 per share. Is New 90 Day High Low • Nov 24
New 90-day high: €30.85 The company is up 4.0% from its price of €29.62 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Multiline Retail industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €30.66 per share. 
